News AC Immune Receives FDA Fast-Track Designation for Alzheimer’s Treatment AC Immune SA, a Swiss-based biotech, announced that it has received fast-track designation from the U.S. Food and Drug Administration (FDA) for its ... By Artur FernandoJuly 4, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024